Neovasc touts NICE health tech assessment as a win – BioWorld Online

Neovasc touts NICE health tech assessment as a win – BioWorld Online

The U.K. National Institute of Health and Care Excellence (NICE) issued two health technology assessments dated Nov. 24, including one that gives a guarded recommendation for devices used to narrow the coronary sinus as a treatment for refractory angina. Neovasc Inc., of Richmond, British Columbia, touted the news as a positive for its Reducer device, given that this is the first instance in which NICE has lent any support for a device to treat the condition.

BioWorld MedTech Regulatory Cardiovascular Europe NICE

Source: https://www.bioworld.com/articles/513724-neovasc-touts-nice-health-tech-assessment-as-a-win